| 1 |
30272343 | Bortezomib improves adoptive carbonic anhydrase IX‑specific chimeric antigen receptor‑modified NK92 cell therapy in mouse models of human renal cell carcinoma. | 2018 Dec |
2 |
| 2 |
26622817 | Bortezomib attenuates HIF-1- but not HIF-2-mediated transcriptional activation. | 2015 Oct |
1 |
| 3 |
20561442 | [Effect of bortezomib on VEGF gene expression of endothelial cell line HMEC-1 and its possible mechanisms]. | 2010 Jun |
1 |
| 4 |
17308115 | Suppression of the hypoxia-inducible factor-1 response in cervical carcinoma xenografts by proteasome inhibitors. | 2007 Feb 15 |
3 |
| 5 |
16061869 | A phase II trial with pharmacodynamic endpoints of the proteasome inhibitor bortezomib in patients with metastatic colorectal cancer. | 2005 Aug 1 |
1 |